<VariationArchive VariationID="952" VariationName="NM_000275.2(OCA2):c.646+1823_807+678delinsAAA" VariationType="Deletion" Accession="VCV000000952" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2015-04-27" MostRecentSubmission="2020-01-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15991" VariationID="952">
      <GeneList>
        <Gene Symbol="OCA2" FullName="OCA2 melanosomal transmembrane protein" GeneID="4948" HGNC_ID="HGNC:8101" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q12-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27719008" stop="28099315" display_start="27719008" display_stop="28099315" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28000020" stop="28344457" display_start="28000020" display_stop="28344457" Strand="-" />
          </Location>
          <OMIM>611409</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000275.2(OCA2):c.646+1823_807+678delinsAAA</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="28018397" stop="28018557" display_start="28018397" display_stop="28018557" variantLength="161" positionVCF="28018396" referenceAlleleVCF="CCTGCTGTGGCCGCCGCCACCTGGAGCCCAAAGCGTCAGCCTGGGTCAGCTCCACCACGATGTGCTCTTCCCTCCCAGGACGACTCGGCCCACTGGCCACTAGGGCCCCTGCCAGGTCCACCTGCAGCAGCGTGGAGTCCACGTGGCTGCTAAGGTTCACGG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28263543" stop="28263703" display_start="28263543" display_stop="28263703" variantLength="161" positionVCF="28263542" referenceAlleleVCF="CCTGCTGTGGCCGCCGCCACCTGGAGCCCAAAGCGTCAGCCTGGGTCAGCTCCACCACGATGTGCTCTTCCCTCCCAGGACGACTCGGCCCACTGGCCACTAGGGCCCCTGCCAGGTCCACCTGCAGCAGCGTGGAGTCCACGTGGCTGCTAAGGTTCACGG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>NM_000275.2:c.647_807del</Name>
        <Name>2.7-KB DEL, EX7DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.28018399_28018559del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.28018399_28018559del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.28263545_28263705del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.28263545_28263705del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009846.2" sequenceAccession="NG_009846" sequenceVersion="2" change="g.85758_85918del">
            <Expression>NG_009846.2:g.85758_85918del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA026559" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611409.0001" DB="OMIM" />
        <XRef Type="rs" ID="1555375711" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Established a molecular definition at the genomic level from the paper by Gao et al., 2017 (PubMed 28451379).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000275.2(OCA2):c.646+1823_807+678delinsAAA AND Brown oculocutaneous albinism" Accession="RCV000001003" Version="13">
        <ClassifiedConditionList TraitSetID="8972">
          <ClassifiedCondition DB="MedGen" ID="C0268497">Brown oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000275.2(OCA2):c.646+1823_807+678delinsAAA AND Tyrosinase-positive oculocutaneous albinism" Accession="RCV000001002" Version="14">
        <ClassifiedConditionList TraitSetID="250">
          <ClassifiedCondition DB="MedGen" ID="C0268495">Tyrosinase-positive oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-09-26" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-26" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2015-04-27" MostRecentSubmission="2020-01-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Manga, P. Identification and molecular characterisation of the genes for brown and rufous oculocutaneous albinism in southern Africa. Ph.D. Thesis: University of the Witwatersrand, Johannesburg 1997.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11179026</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17767372</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7920637</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8972" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8583" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Brown oculocutaneous albinism</ElementValue>
                <XRef ID="11160000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BOCA</ElementValue>
                <XRef ID="203200" DB="OMIM" />
              </Symbol>
              <XRef ID="C0268497" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="198" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinoidism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinase-positive oculocutaneous albinism</ElementValue>
                <XRef ID="Oculocutaneous+albinism+type+2/5317" DB="Genetic Alliance" />
                <XRef ID="26336006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALBINISM II</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA2</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4038" />
                <XRef ID="4038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37053367</ID>
                <ID Source="BookShelf">NBK590568</ID>
              </Citation>
              <XRef ID="79432" DB="Orphanet" />
              <XRef ID="C0268495" DB="MedGen" />
              <XRef ID="MONDO:0008746" DB="MONDO" />
              <XRef Type="MIM" ID="203200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21152" SubmissionDate="2018-02-13" DateLastUpdated="2015-04-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611409.0001_ALBINISM, OCULOCUTANEOUS, TYPE II" title="OCA2, 2.7-KB DEL, EX7DEL_ALBINISM, OCULOCUTANEOUS, TYPE II" />
        <ClinVarAccession Accession="SCV000021152" DateUpdated="2015-04-27" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a consanguineous kindred with oculocutaneous albinism type II (OCA2; 203200), Durham-Pierre et al. (1994) identified a homozygous 2.7-kb deletion encompassing an exon of the P gene. The kindred was of African, Caucasian, and American Indian descent. The same deletion allele was identified in unrelated African Americans, Haitian, and Africans with OCA2, suggesting a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">7920637</ID>
              </Citation>
              <XRef DB="OMIM" ID="203200" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Brown oculocutaneous albinism (BOCA) is also linked to the P locus, and the occurrence of both OCA2 and BOCA within the same family suggested that these disorders are allelic. Manga (1997) found that a large proportion (9/10) of BOCA subjects were compound heterozygotes with the 2.7-kb deletion of the OCA2 gene on one allele. Manga et al. (2001) demonstrated that 10 persons with brown oculocutaneous albinism in southern Africa were heterozygous for the 2.7-kb deletion. They did not succeed in defining the second mutation but presumed that it was a milder mutation, possibly in the promoter region (downregulating expression) or in other regions of the P gene they did not screen.</Attribute>
              <Citation>
                <ID Source="PubMed">11179026</ID>
              </Citation>
              <Citation>
                <CitationText>Manga, P. Identification and molecular characterisation of the genes for brown and rufous oculocutaneous albinism in southern Africa. Ph.D. Thesis: University of the Witwatersrand, Johannesburg 1997.</CitationText>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">By analyzing a 5-SNP haplotype of the OCA2 gene in 53 unrelated Cameroonian OCA2 patients homozygous for the 2.7-kb deletion and 48 ethnically matched controls, Aquaron et al. (2007) estimated that the mutation originated 4,100 to 5,645 years ago.</Attribute>
              <Citation>
                <ID Source="PubMed">17767372</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <Name>OCA2, 2.7-KB DEL, EX7DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2.7-KB DEL, EX7DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611409.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALBINISM, OCULOCUTANEOUS, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="21153" SubmissionDate="2018-02-13" DateLastUpdated="2015-04-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611409.0001_BROWN OCULOCUTANEOUS ALBINISM" title="OCA2, 2.7-KB DEL, EX7DEL_BROWN OCULOCUTANEOUS ALBINISM" />
        <ClinVarAccession Accession="SCV000021153" DateUpdated="2015-04-27" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a consanguineous kindred with oculocutaneous albinism type II (OCA2; 203200), Durham-Pierre et al. (1994) identified a homozygous 2.7-kb deletion encompassing an exon of the P gene. The kindred was of African, Caucasian, and American Indian descent. The same deletion allele was identified in unrelated African Americans, Haitian, and Africans with OCA2, suggesting a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">7920637</ID>
              </Citation>
              <XRef DB="OMIM" ID="203200" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Brown oculocutaneous albinism (BOCA) is also linked to the P locus, and the occurrence of both OCA2 and BOCA within the same family suggested that these disorders are allelic. Manga (1997) found that a large proportion (9/10) of BOCA subjects were compound heterozygotes with the 2.7-kb deletion of the OCA2 gene on one allele. Manga et al. (2001) demonstrated that 10 persons with brown oculocutaneous albinism in southern Africa were heterozygous for the 2.7-kb deletion. They did not succeed in defining the second mutation but presumed that it was a milder mutation, possibly in the promoter region (downregulating expression) or in other regions of the P gene they did not screen.</Attribute>
              <Citation>
                <ID Source="PubMed">11179026</ID>
              </Citation>
              <Citation>
                <CitationText>Manga, P. Identification and molecular characterisation of the genes for brown and rufous oculocutaneous albinism in southern Africa. Ph.D. Thesis: University of the Witwatersrand, Johannesburg 1997.</CitationText>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">By analyzing a 5-SNP haplotype of the OCA2 gene in 53 unrelated Cameroonian OCA2 patients homozygous for the 2.7-kb deletion and 48 ethnically matched controls, Aquaron et al. (2007) estimated that the mutation originated 4,100 to 5,645 years ago.</Attribute>
              <Citation>
                <ID Source="PubMed">17767372</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <Name>OCA2, 2.7-KB DEL, EX7DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2.7-KB DEL, EX7DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611409.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">BROWN OCULOCUTANEOUS ALBINISM</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2237646" SubmissionDate="2019-09-26" DateLastUpdated="2020-01-04" DateCreated="2020-01-04">
        <ClinVarSubmissionID localKey="NM_000275.2:c.647_807del|OMIM:203200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001133108" DateUpdated="2020-01-04" DateCreated="2020-01-04" Type="SCV" Version="1" SubmitterName="Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City" OrgID="506517" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.2:c.647_807del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6349585</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="21152" TraitType="Disease" MappingType="Name" MappingValue="ALBINISM, OCULOCUTANEOUS, TYPE II" MappingRef="Preferred">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="21153" TraitType="Disease" MappingType="Name" MappingValue="BROWN OCULOCUTANEOUS ALBINISM" MappingRef="Alternate">
        <MedGen CUI="C0268497" Name="Brown oculocutaneous albinism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2237646" TraitType="Disease" MappingType="XRef" MappingValue="203200" MappingRef="OMIM">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

